Jochen H. Lorch, MD, MS
Advertisement
Articles by Jochen H. Lorch, MD, MS
A key opinion leader reviews the case of a 71-year-old woman with NTRK gene fusion thyroid cancer and considers novel therapies available for the management of her disease.
Advertisement
Latest Updated Articles
Preferred Testing Methods and Treatment OptionsSeptember 21st 2020
- LOXO-101 Trial Regimen Overview
September 21st 2020
- A 71-Year-Old Woman With NTRK Gene Fusion Thyroid Cancer
September 21st 2020
- NTRK Gene Fusion Thyroid Cancer: Incidence and Prognosis
September 21st 2020
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Anito-Cel Delivers Durable Responses With Low Neurotoxicity in RRMM
2
Risk, Histology, and Metastatic Site Guide First-Line RCC Treatment Choices
3
FDA Application Withdrawn for I-DXd in Small Cell Lung Cancer
4
Elinzanetant Gets Priority Review for VMS From Breast Cancer Endocrine Therapy
5